Huda Salman
Clinical trials sponsored by Huda Salman, explained in plain language.
-
Engineered T-Cells take aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called CD4CAR for people with T-cell leukemia or lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target and attack cancer cells. The main goal is t…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
Engineered immune cells aim to clear leukemia before transplant
Disease control Recruiting nowThis early-phase trial tests a new treatment for adults and teens with a hard-to-treat form of acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses specially engineered immune cells (CAR T-cells) that target a protein called CD4…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated May 26, 2026 06:46 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Recruiting nowThis early-stage trial tests a new treatment called CD4CAR T cells for people with a rare blood cancer called CMML that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target and attack cancer cells. The ma…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated May 22, 2026 13:52 UTC